Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs W.R. Berkley Corporation Common Stock (WRB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs W.R. Berkley Corporation Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B), while W.R. Berkley Corporation Common Stock trades at $74.93 (market cap $27.40B). The key difference: W.R. Berkley Corporation Common Stock is far larger — about 3.1× Kymera Therapeutics Inc. Common Stock's market cap, and W.R. Berkley Corporation Common Stock pays a 0.54% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and W.R. Berkley Corporation Common Stock for 0 Days on average.
| KYMR | WRB | |
|---|---|---|
Market Cap | $8.88B | $27.40B |
Volume | 1,028,790 | 2,015,378 |
Sector | Health | Financials |
52-Week High | $127.31 | $78.10 |
52-Week Low | $55.80 | $63.54 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.27B | $27.64B |
Dividend Yield | — | 0.54% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About W.R. Berkley Corporation Common Stock
W.R. Berkley Corporation is an insurance holding company that underwrites commercial property and casualty insurance and reinsurance through its Insurance and Reinsurance & Monoline Excess segments.
Read more on WRB →
